Solural Pharma ApS receives an updated Manufacturing and Importation Authorisation No. 30108 by the Danish Health and Medicines Authority expanding its manufacturing capabilities from oral products to also include topical products and primary and secondary packaging of Investigational Medicinal Products.
Recent news
- New patent acquisition agreement November 16, 2022
- New Eurasia patent December 25, 2020
- New Manufacturing Authorisation December 18, 2020
Career
If you are interested in joining Solural Pharma ApS, we are seeking professionals, technicians and consultants with expertise within drug development. Please contact
career@soluralpharma.com for more information about available positions.